ICAM1 and head and neck squamous cell carcinoma: As expected, PIO significantly attenuated the increase in intracellular ROS levels in CM-treated HNSCC cells (Figure 4E) and CM-induced ICAM1 protein levels on Western blotting (Figure 4F).